Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ11571158-2,44
KB11251126-0,27
PKN128,94128,980,05
Msft403,53403,62-0,32
Nokia7,117,1223,45
IBM247,85248,23-0,33
Mercedes-Benz Group AG54,5554,58-0,60
PFE26,9126,92-1,41
12.03.2026 15:14:00
Indexy online
AD Index online
select
AD Index online
 

  • 12.03.2026 15:08:37
LPL Financial (LPLA.O, NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
299,80 -1,26 -3,82 15 631 630
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti

Business Summary: LPL Financial Holdings Inc. is an independent broker-dealer and an investment advisory firm. The Company offers an integrated platform of brokerage and investment advisory services to independent financial advisors and financial advisors at institutions in the United States. Through its comprehensive platform, it offers integrated technology solutions; brokerage and advisory platforms; clearing, compliance, business and planning and advice services; consultative practice management programs and training, and in-house research. Through its custody and clearing platform, using both proprietary and third-party technology, it offers access to diversified financial products and services, enabling its advisors to offer personalized financial advice and brokerage services to retail investors. Its products include alternative investments, annuities, exchange-traded products, insurance-based products, mutual funds, and retirement plan products. It also offers wealth management solutions.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, LPL Financial Holdings Inc revenues increased 37% to $16.99B. Net income decreased 18% to $863M. Revenues reflect Advisory increase of 49% to $8.16B, Commission increase of 36% to $4.51B, Total asset increase of 20% to $3B. Net income was offset by Commission and advisory increase of 45% to $11.2B (expense), Occupancy and equipment increase from $281.2M to $577.2M (expense).



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, Chief Executive OfficerPhillip Frost8827.03.200727.03.2007
President, Vice Chairman of the BoardElias Zerhouni7309.05.202209.05.2022
Vice Chairman of the Board, Chief Technical OfficerJane Hsiao7704.05.200704.05.2007
Chief Financial Officer, Senior Vice President, Chief Accounting Officer, TreasurerAdam Logal4627.03.2007
Chief Executive Officer of OPKO RenalCharles Bishop73
Chief Executive Officer, Transition Therapeutics, IncTony Cruz71
Executive Vice President - Administration, DirectorSteven Rubin6404.05.200704.05.2007
Chief Innovation Officer, DirectorGary Nabel7109.05.202209.05.2022